Glucocorticoids and the ups and downs of neuropeptide gene expression

Birth, Distress and Disease: Placental-Brain Interactions

Volumn , Issue , 2005, Pages 202-234

  Watts, Alan G ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33746142436     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545658.009     Document Type: Chapter

References (90)

1. Aguilera, G., Kiss, A. and Luo, X. (1995). Increased expression of type 1 angiotensin II receptors in the hypothalamic paraventricular nucleus following stress and glucocorticoid administration. J. Neuroendocrinol., 7, 775-83.
2. Akana, S. F., Cascio, C. S., Du, J. Z., Levin, N. and Dallman, M. F. (1986). Reset of feedback in the adrenocortical system: an apparent shift in sensitivity of adrenocorticotropin to inhibition by corticosterone between morning and evening. Endocrinology, 119, 2325-32.
3. Akabayashi, A., Watanabe, Y., Wahlestedt, C. et al. (1994).Hypothalamic neuropeptide Y, its gene expression and receptor activity: relation to circulating corticosterone in adrenalectomized rats. Brain Res., 665, 201-12.
4. Beato, M., Herrlich, P. and Schutz, G. (1995). Steroid hormone receptors: many actors in search of a plot. Cell, 83, 851-7.
5. Beyer, H. S., Matta, S. G. and Sharp, B. M. (1988). Regulation of messenger ribonucleic acid for corticotropin-releasing factor in the paraventricular nucleus and other brain sites in the rat. Endocrinology, 123, 2117-23.
6. Brann, D. W., Hendry, L. B. and Mahesh, V. B. (1995). Emerging diversities in the mechanism of action of steroid hormones. J. Steroid Biochem.Mol. Biol., 52, 113-33.
7. Buijs, R. M., Kalsbeek, A., van der Woude, T. P., van Heerikhuize, J. J. and Shinn, S. (1993a). Suprachiasmatic nucleus lesion increases corticosterone secretion. Am. J. Physiol., 264, R1186-92.
8. Buijs, R. M., Markman, M., Nunes-Cardoso, B., Hou, Y. X. and Shinn, S. (1993b). Projections of the suprachiasmatic nucleus to stress-related areas in the rat hypothalamus: a light and electron microscopic study. J. Comp. Neurol., 335, 42-54.
9. Buijs, R. M., Hermes, M. H. and Kalsbeek, A. (1998). The suprachiasmatic nucleus-paraventricular nucleus interactions: a bridge to the neuroendocrine and autonomic nervous system. Prog. Brain Res., 119, 365-82.
10. Burke, Z. D., Ho, M. Y., Morgan, H. et al. (1997). Repression of vasopressin gene expression by glucocorticoids in transgenic mice: evidence of a direct mechanism mediated by proximal 5 flanking sequence. Neuroscience, 78, 1177-85.
11. Cascio, C. S., Shinsako, J. and Dallman, M. F. (1987). The suprachiasmatic nuclei stimulate evening ACTH secretion in the rat. Brain Res., 423, 173-8.
12. Chou, T. C., Scammell, T. E., Gooley, J. J. et al. (2003). Critical role of dorsomedial hypothalamic nucleus in a wide range of behavioral circadian rhythms. J. Neurosci., 23, 10691-702.
13. Cullinan, W. E., Herman, J. P. and Watson, S. J. (1993). Ventral subicular interaction with the hypothalamic paraventricular nucleus: evidence for a relay in the bed nucleus of the stria terminalis. J. Comp. Neurol., 332, 1-20.
14. Dallman, M. F., Akana, S. F., Cascio, C. S. et al. (1987). Regulation of ACTH secretion: variations on a theme of B. Recent Prog. Horm. Res., 43, 113-73.
15. Dallman, M. F., Akana, S. F., Bhatnagar, S., Bell, M. E. and Strack, A. M. (2000). Bottomed out: metabolic significance of the circadian trough in glucocorticoid concentrations. Int. J. Obes. Relat.Metab. Disord., 24(Suppl 2), S40-6.
16. Darlington, D. N., Barraclough, C. A. and Gann, D. S. (1992). Hypotensive hemorrhage elevates corticotropin-releasing hormone messenger ribonucleic acid (mRNA) but not vasopressin mRNA in the rat hypothalamus. Endocrinology, 130, 1281-88.
17. Day, H. E., Campeau, S., Watson Jr., S. J. and Akil, H. (1999). Expression of alpha (1b) adrenoceptor mRNA in corticotropin-releasing hormone-containing cells of the rat hypothalamus and its regulation by corticosterone. J. Neurosci., 19, 10098-106.
18. Dong, H. W., Petrovich, G. D. and Swanson, L. W. (2001a). Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res.-Brain Res. Rev., 38, 192-246.
19. Dumont, J. E., Dremier, S., Pirson, I. and Maenhaut, C. (2002). Cross signaling, cell specificity, and physiology. Am. J. Physiol. Cell. Physiol., 283, C2-28.
20. Frim, D. M., Robinson, B. G., Pasieka, K. B. and Majzoub, J. A. (1990). Differential regulation of corticotropin-releasing hormone mRNA in rat brain. Am. J. Physiol., 258, E686-92.
21. Guardiola-Diaz, H. M., Kolinske, J. S., Gates, L. H. and Seasholtz, A. F. (1996). Negative glucocorticoid regulation of cyclic adenosine 3,5 -monophosphate-stimulated corticotropin releasing hormone-reporter expression in AtT-20 cells.Mol. Endocrinol., 10, 317-29.
22. Hallbeck, M., Larhammar, D. and Blomqvist, A. (2001). Neuropeptide expression in rat paraventricular hypothalamic neurons that project to the spinal cord. J. Comp.Neurol., 433, 222-38.
23. Herman, J. P. (1995). In-situ hybridization analysis of vasopressin gene-transcription in the paraventricular and supraoptic nuclei of the rat-regulation by stress and glucocorticoids. J. Comp. Neurol., 363, 15-27.
24. Herman, J. P., Tasker, J. G., Ziegler, D. R. and Cullinan, W. E. (2002). Local circuit regulation of paraventricular nucleus stress integration: glutamate-GABA connections. Pharmacol. Biochem. Behav., 71, 457-68.
25. Hohlweg, W. and Junkmann, K. (1932). Die hormonal-nervose Regulierung der Funktion der Hypophysenborderlappens. Klin. Wschr., 11, 321-23.
26. Hoskins, R. G. (1949). The thyroid-pituitary apparatus as a servo (feedback) mechanism. J. Clin. Endocrinol., 9, 1429-31.
27. Itoi, K., Helmreich, D. L., Lopez-Figueroa, M. O. and Watson, S. J. (1999). Differential regulation of corticotropin-releasing hormone and vasopressin gene transcription in the hypothalamus by norepinephrine. J. Neurosci., 19, 5464-72.
28. Ixart, G., Alonso, G., Szafarczyk, A. et al. (1982). Adrenocorticotropic regulations after bilateral lesions of the paraventricular or supraoptic nuclei and in Brattleboro rats.Neuroendocrinology, 35, 270-6.
29. Ixart, G., Conte-Devolx, B., Szafarczyk, A. et al. (1985). L'immunisation passive avec un immuneserum anti-oCRF41 inhibe l'augmentation circadienne de l'ACTH plasmatique chez le rat. CR Acad. Sci. III, 301, 659-64.
30. Jhanwar-Uniyal, M. and Leibowitz, S. F. (1986). Impact of circulating corticosterone on alpha 1-and alpha 2-noradrenergic receptors in discrete brain areas. Brain Res., 368, 404-8.
31. Jones, M. T. and Gillham, B. (1988). Factors involved in the regulation of adrenocorticotropic hormone/beta-lipotropic hormone. Physiol. Rev., 68, 743-818.
32. Kalsbeek, A., van Heerikhuize, J. J., Wortel, J. and Buijs, R. M. (1996). A diurnal rhythm of stimulatory input to the hypothalamo-pituitary-adrenal system as revealed by timed intrahypothalamic administration of the vasopressin V1 antagonist. J. Neurosci., 16, 5555-65.
33. Keller-Wood, M. E. and Dallman, M. F. (1984). Corticosteroid inhibition of ACTH secretion. Endocr. Rev., 5, 1-24.
34. Khan, A. M. and Watts, A. G. (2003). Norepinephrine rapidly elevates CRH hnRNA, c-fos mRNA, and levels of phosphorylated MAP kinases (Erk 1 and 2) in hypothalamic parvocellular paraventricular neurons in vivo. Soc. Neurosci. Absts.
35. Khan, A. M. and Watts, A. G. (2004). Intravenous 2-deoxy-D-glucose injection rapidly elevates levels of the phosphorylated forms of p44/42 mitogen activated protein kinases (Erk 1/2) in rat hypothalamic parvocellular paraventricular neurons. Endocrinology, 145, 351-59.
36. King, B. R., Smith, R. and Nicholson, R. C. (2002). Novel glucocorticoid and cAMP interactions on the CRH gene promoter.Mol. Cell Endocrinol., 194, 19-28.
37. Kovacs, K. J. (1998). Functional neuroanatomy of the parvocellular vasopressinergic system: transcriptional responses to stress and glucocorticoid feedback. Prog. Brain Res., 119, 31-43.
38. Kovacs, K. J. and Mezey, E. (1987). Dexamethasone inhibits corticotropin-releasing factor gene expression in the rat paraventricular nucleus. Neuroendocrinology, 46, 365-8.
39. Kovacs, K. J. and Sawchenko, P. E. (1996a). Sequence of stress-induced alterations in indices of synaptic and transcriptional activation in parvocellular neurosecretory neurons. J. Neurosci., 16, 262-73.
40. Kovacs, K. J. and Sawchenko, P. E. (1996b). Regulation of stress-induced transcriptional changes in the hypothalamic neurosecretory neurons. J.Mol. Neurosci., 7, 125-33.
41. Kovacs, K. J., Foldes, A. and Sawchenko, P. E. (2000). Glucocorticoid negative feedback selectively targets vasopressin transcription in parvocellular neurosecretory neurons. J. Neurosci., 20, 3843-52.
42. Kretz, O., Reichardt, H. M., Schutz, G. and Bock, R. (1999). Corticotropin-releasing hormone expression is the major target for glucocorticoid feedback-control at the hypothalamic level. Brain Res., 818, 488-91.
43. Laugero, K. D., Bell, M. E., Bhatnagar, S., Soriano, L. and Dallman, M. F. (2001). Sucrose ingestion normalizes central expression of corticotropin-releasing-factor messenger ribonucleic acid and energy balance in adrenalectomized rats: a glucocorticoid-metabolic-brain axis? Endocrinology, 142, 2796-804.
44. Leak, R. K. and Moore, R. Y. (2001). Topographic organization of suprachiasmatic nucleus projection neurons. J. Comp. Neurol., 433, 312-34.
45. Legradi, G., Holzer, D., Kapcala, L. P. and Lechan, R. M. (1997). Glucocorticoids inhibit stressinduced phosphorylation of CREB in corticotropin-releasing hormone neurons of the hypothalamic paraventricular nucleus. Neuroendocrinology, 66, 86-97.
46. Lightman, S. L. and Harbuz, M. S. (1993). Expression of corticotropin-releasing factor mRNA in response to stress. CIBA Found. Symp., 172, 173-87.
47. Ma, X. M., Levy, A. and Lightman, S. L. (1997). Rapid changes of heteronuclear RNA for arginine vasopressin but not for corticotropin releasing hormone in response to acute corticosterone administration. J. Neuroendocrinol., 9, 723-8.
48. Ma, X. M. and Aguilera, G. (1999). Differential regulation of corticotropin-releasing hormone and vasopressin transcription by glucocorticoids. Endocrinology, 140, 5642-50.
49. Ma, X. M., Camacho, C. and Aguilera, G. (2001). Regulation of corticotropin-releasing hormone (CRH) transcription and CRH mRNA stability by glucocorticoids. Cell Mol. Neurobiol., 21, 465-75.
50. Majzoub, J. A., Emanuel, R., Adler, G. et al. (1993). Second messenger regulation of mRNA for corticotropin-releasing factor. CIBA Found. Symp., 172, 30-43.
51. Makino, S., Gold, P.W. and Schulkin, J. (1994). Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus. Brain Res., 657, 141-9.
52. Malkoski, S. P., Handanos, C. M. and Dorin, R. I. (1997). Localization of a negative glucocorticoid response element of the human corticotropin-releasing hormone gene. Mol. Cell. Endocrinol., 127, 189-99.
53. Malkoski, S. P. and Dorin, R. I. (1999). Composite glucocorticoid regulation at a functionally defined negative glucocorticoid response element of the human corticotropin-releasing hormone gene.Mol. Endocrinol., 13, 1629-44.
54. Moore, C. R. and Price, D. (1932). Gonad hormone functions, and the reciprocal influence of between gonads and hypophysis with its bearing on the problem of sex hormone antagonism. Am. J. Anat., 50, 13-71.
55. Moore, R. Y. and Eichler, V. B. (1972). Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat. Brain Res., 42, 201-6.
56. Muglia, L. J., Jacobson, L., Weninger S. C. et al. (1997). Impaired diurnal adrenal rhythmicity restored by constant infusion of corticotropin-releasing hormone in corticotropin-releasing hormone-deficient mice. J. Clin. Invest., 99, 2923-9.
57. Plotsky, P. M. and Vale, W. (1984). Hemorrhage-induced secretion of corticotropin-releasing factorlike immunoreactivity into the rat hypophysial portal circulation and its inhibition by glucocorticoids. Endocrinology, 114, 164-9.
58. Plotsky, P. M., Bruhn, T. O. and Vale, W. (1985). Evidence for multifactorial regulation of adrenocorticotropin secretory response to hemodynamic stimuli. Endocrinology, 116, 633-9.
59. Reichardt, H. M., Kaestner, K. H., Tuckermann, J. et al. (1998). DNA-binding of the glucocorticoid receptor is not essential for survival. Cell, 93, 531-41.
60. Ritter, S., Watts, A. G., Dinh, T. T., Sanchez-Watts, G. and Pedrow, C. (2003). Immunotoxin lesion of hypothalamically projecting norepinephrine and epinephrine neurons differentially affects circadian and stressor-stimulated corticosterone secretion. Endocrinology, 144, 1357-67.
61. Sapolsky, R. M., Romero, L. M. and Munck, A. U. (2000).How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev., 21, 55-89.
62. Sawchenko, P. E., Li, H. Y. and Ericsson, A. (2000). Circuits and mechanisms governing hypothalamic responses to stress: a tale of two paradigms. Prog. Brain Res., 122, 61-78.
63. Schneider, J. E. and Watts, A. G. (2002). Energy homeostasis and behavior. In D. W. Pfaff, Sr. ed., Hormones, Brain, and Behavior, Vol. 1. Academic Press, pp. 435-523.
64. Shelat, S. G., Fluharty, S. J. and Flanagan-Cato, L. M. (1998).Adrenal steroid regulation of central angiotensin II receptor subtypes and oxytocin receptors in rat brain. Brain Res., 807, 135-46.
65. Swanson, L. W. (1991). Biochemical switching in hypothalamic circuits mediating responses to stress. Prog. Brain Res., 87, 181-200.
66. Swanson, L. W. (2000). Cerebral hemisphere regulation of motivated behavior. Brain Res., 886, 113-64.
67. Swanson, L. W. and Kuypers H. G. (1980). The paraventricular nucleus of the hypothalamus: cytoarchitectonic subdivisions and organization of projections to the pituitary, dorsal vagal complex, and spinal cord as demonstrated by retrograde fluorescence double-labeling methods. J. Comp. Neurol., 194, 555-70.
68. Swanson, L.W. and Sawchenko, P. E. (1983).Hypothalamic integration: organization of the paraventricular and supraoptic nuclei.Annu. Rev. Neurosci., 6, 275-325.
69. Swanson, L. W. and Simmons, D. M. (1989). Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat. J. Comp. Neurol., 285, 413-35.
70. Szafarczyk, A., Ixart, G., Malaval, F., Nouguier-Soule, J. and Assenmacher, I. (1979). Effects of lesions of the suprachiasmatic nuclei and of p-chlorophenylalanine on the circadian rhythms of adrenocorticotrophic hormone and corticosterone in the plasma, and on locomotor activity of rats. J. Endocrinol., 83, 1-16.
71. Tanimura, S. M. and Watts, A. G. (1998). Corticosterone can facilitate as well as inhibit CRH gene expression in the rat hypothalamic paraventricular nucleus. Endocrinology, 139, 3830-37.
72. Tanimura, S. M. and Watts, A. G. (2000). Adrenalectomy dramatically modifies the dynamics of neuropeptide and c-fos gene responses to stress in the hypothalamic paraventricular nucleus. J. Neuroendocrinol., 12, 715-22.
73. Tanimura, S. M., Sanchez-Watts, G. and Watts, A. G. (1998). Peptide gene activation, secretion, and steroid feedback during stimulation of rat neuroendocrine CRH neurons. Endocrinology, 139, 3822-9.
74. Thompson, R. H. and Swanson, L. W. (1998). Organization of inputs to the dorsomedial nucleus of the hypothalamus: a reexamination with Fluorogold and PHAL in the rat. Brain Res.-Brain Res. Rev., 27, 89-118.
75. Thompson, R. H., Canteras, N. S. and Swanson, L.W. (1996). Organization of projections from the dorsomedial nucleus of the hypothalamus: a PHA-L study in the rat. J.Comp.Neurol., 376, 143-73.
76. Vrang, N., Larsen, P. J., Moller, M. and Mikkelsen, J. D. (1995a). Topographical organization of the rat suprachiasmatic-paraventricular projection. J. Comp. Neurol., 353, 585-603.
77. Vrang, N., Larsen, P. J. and Mikkelsen, J. D. (1995b). Direct projection from the suprachiasmatic nucleus to hypophysiotrophic corticotropin-releasing factor immunoreactive cells in the paraventricular nucleus of the hypothalamus demonstrated by means of Phaseolus vulgarisleucoagglutinin tract tracing. Brain Res., 684, 61-9.
78. Watts, A. G. (1992). Disturbance of fluid homeostasis leads to temporally and anatomically distinct responses in neuropeptide and tyrosine hydroxylase mRNA levels in the paraventricular and supraoptic nuclei of the rat. Neuroscience, 46, 859-79.
79. Watts, A. G. (1996). The impact of physiological stimulation on the expression of corticotropin releasing hormone and other neuropeptide genes. Front. Neuroendocrinol., 17, 281-326.
80. Watts, A. G. (2000). Comparative anatomy and physiology. In George Fink, Sr. ed., The Encyclopedia of Stress. Academic Press, San Diego, CA, USA, pp. 507-11.
81. Watts, A. G., Swanson, L. W. and Sanchez-Watts, G. (1987). Efferent projections of the suprachiasmatic nucleus. I. Studies using anterograde transport of Phaseolus vulgaris leucoagglutinin (PHA-L) in the rat. J. Comp. Neurol., 258, 204-29.
82. Watts, A. G. and Sanchez-Watts, G. (1995a). Region-specific regulation of neuropeptide mRNAs in rat limbic forebrain neurones by aldosterone and corticosterone. J. Physiol. (London), 484, 721-36.
83. Watts, A. G. and Sanchez-Watts, G. (1995b). Physiological regulation of peptide messenger RNA colocalization in rat hypothalamic paraventricular medial parvicellular neurons. J. Comp. Neurol., 352, 501-14.
84. Watts, A. G. and Sanchez-Watts, G. (2002). Interactions between heterotypic stressors and corticosterone reveal integrative mechanisms for controlling CRH gene expression in the rat paraventricular nucleus. J. Neurosci., 22, 6282-9.
85. Watts, A. G. and Swanson, L. W. (2002). Anatomy of motivational systems. In Hal Pashler and Randy Gallistell, eds., Stevens' Handbook of Experimental Psychology, Vol. 3, Learning, Motivation, and Emotion, 3rd edn. John Wiley & Sons, New York, NY, USA, pp. 563-632.
86. Watts, A. G., Tanimura, S. M. and Sanchez-Watts, G. (2004). Crh and avp gene transcription in the hypothalamic paraventricular nucleus of unstressed rats: daily rhythms and their corticosterone dependence. Endocrinology, 145, 529-40.
87. Weiner, N. (1948). Cybernetics. New York: Technology Press/Wiley & Sons.
88. Whitnall, M. H. (1993). Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog. Neurobiol., 40, 573-629.
89. Wolfl, S., Martinez, C. and Majzoub, J. A. (1999). Inducible binding of cyclic adenosine 3, 5 -monophosphate (cAMP)-responsive element binding protein (CREB) to a cAMP-responsive promoter in vivo.Mol. Endocrinol., 13, 659-69.
90. Yates, F. E. and Maran, J. W. (1974). Stimulation and inhibition of adrenocorticotropin release. In Knobil, E. and Sawyer, W. H., eds., Handbook of Physiology, Vol. IV, Part 2. The Pituitary and its Neuroendocrine Control, Washington. DC: American Physiological Society, pp. 367-404.